GlaxoSmithKline plc (ADR) (NYSE:GSK)

CAPS Rating: 4 out of 5

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

Recs

0
Player Avatar TMFBuck (76.63) Submitted: 8/18/2011 3:20:29 PM : Outperform Start Price: $39.45 GSK Score: -3.84

Access to and strength in emerging markets. A strong dividend is currently underappreciated.

Featured Broker Partners


Advertisement